Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Weight loss - You Need To See This

The Hidden Side Effect of Weight-Loss Injections That Men Aren’t Talking About

Weight-loss injections continue to reshape conversations around obesity treatment and metabolic health. Men across different age groups report rapid drops in appetite and steady weight loss that once felt difficult to achieve. Clinics highlight improvements in blood sugar control, waist size, and cardiovascular markers.

Clever Dude

Weight loss drugs could widen health inequalities, experts warn

Researchers argue the long-term benefits of weight loss jabs depend on nutrition advice and support

The Independent UK

Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms?

Even before receiving public funding, Wegovy has drawn much media attention in New Zealand for the dramatic difference it can make for weight loss.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Trying to lose weight? Scientists just revealed the exact number of steps you should do - and it’s fewer than 10,000

The study looked at how many steps participants took to lose weight and how many to help keep it off

Woman & Home

India’s GLP-1 Weight Loss Drug Problem Nobody Is Warning You About

A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs…

MyLifeXP

Could GLP-1 Drugs Do More Than Aid Weight Loss? Some Studies Link Them to Lower Tumor Risk

GLP-1 medications already changed the conversation around weight loss, diabetes care, and metabolic health. Now researchers explore an even more intriguing question: could these drugs influence cancer risk as well. Early studies continue to spark interest because they show patterns that go beyond appetite control and blood sugar regulation.

Clever Dude

Kelly Osbourne's 'Skeletal' Viral Photos Trigger Fierce Debate Over Hollywood Beauty Standards

Kelly Osbourne's latest viral photos reopened conversations about Ozempic, body image and the return of 'heroin chic' trends in Hollywood.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Truth Behind Kelly Osbourne's 'Skeletal' Photo: Star Slams 'Cruel' Comments Over Louis Vuitton Look

Kelly Osbourne faces backlash over a viral photo showing her emaciated look, sparking debate about its authenticity. She addresses body shaming and clarifies her weight loss journey.

International Business Times UK

10 Photos of Kim Ji-Won as Netizens Question Her Sudden Weight Loss and 'Drastic' Facial Transformation

South Korean actress Kim Ji-Won's drastic and quick physical transformation has sparked online debate.

International Business Times UK

Older adults using GLP-1s should pay particular attention to three things, according to the CEO of the American Council on Exercise

"The importance of preserving strength, physical function and lean mass generally increases with age," says Cedric X. Bryant, PhD

Fit & Well

GLP‑1 Weight-Loss Pill Launches: Oral Options Like Wegovy Could Make Injections Obsolete

For years, GLP-1 drugs like Wegovy and Ozempic transformed weight management, but they came with one major drawback: injections. That barrier kept many people from even asking their doctor about treatment. Now, the rise of the oral GLP-1 weight-loss pill is changing the conversation in a big way. With daily…

Budget and the Bees

The Cost and Consequences of GLP-1 Agonists: Are They Worth the Long-Term Investment?

Shedding light on the advantages and disadvantages of continued use of GLP-1 agonists for users.

International Business Times UK

Mindy Kaling's Shocking Weight Loss Sparks Debate: Longtime Fans Say They Feel 'Disconnected' From Her New Look

Mindy Kaling shares her weight loss journey, prioritising health over vanity, amidst public scrutiny and mixed reactions from fans.

International Business Times UK

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

Budget and the Bees

GLP‑1 Peptides Cause Lean Muscle Loss—Study Finds Users Lose About 1.9 Pounds of Muscle (25% of Weight Lost)

For many people taking GLP-1 medications like Ozempic, Wegovy, or Zepbound, the number on the scale finally starts moving in the right direction. But newer research is raising a tougher question: what exactly is being lost besides fat? Some studies suggest that about 25% of weight lost on GLP-1 therapy…

The Guardian - UK

From high BMI to the ‘GLP-1 look’: how weight-loss jabs are changing the face of beauty

Experts say exponential growth in the use of drugs such as Wegovy is shifting our perception of what is attractive

International Business Times UK

Did Ryan Seacrest Undergo Plastic Surgery? Unrecognisable Host Insists Everything Is Fine Amid Face Panic

Fans say Ryan Seacrest looks 'unrecognisable' in new public appearances and Instagram selfies, fuelling speculation about buccal fat removal and his rapid weight loss.

Reason

Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug

Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

How does your body lose weight? An obesity doctor explains why one size doesn’t fit all in weight loss

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they desire. But it is much more complicated.

Budget and the Bees

Peptide Injections Are Booming — But Unapproved Versions May Cause Skin Cancer and Other Risks

From weight loss and anti-aging to faster muscle recovery, peptide injections have exploded across social media, wellness clinics, and telehealth platforms. Influencers promote them as cutting-edge shortcuts for better health, while patients facing long waits or high prices for prescription drugs often look for alternatives. But not all peptide injections…

The Economic Times

Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?

Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplements. This is to prevent nutritional deficiencies and muscle loss due to reduced food intake. Sales…

MarketBeat

Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first durability and progression-free survival data for the company’s highlighted cervical and head and neck canc

The Guardian - US

New weight-loss shot appears to outperform other obesity drugs on market

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs

International Business Times UK

Unrecognisable Jack Osbourne Slams Media Claims That He Is Sick and Grossly Underweight

Jack Osbourne has blasted claims he is 'grossly underweight', insisting his four‑stone weight loss is the product of years of training and sobriety, not a secret illness.

MarketBeat

From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook

Eli Lilly just got more good news, posting promising results for its oral GLP-1 as the firm looks to unlock new sources of demand.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Corbus Pharmaceuticals

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.